Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
24 Apr 2026 |
CH04 |
Secretary's details changed for Vistra Cosec Limited on 2 March 2026
|
|
|
25 Sep 2025 |
CS01 |
Confirmation statement made on 22 September 2025 with updates
|
|
|
27 Aug 2025 |
AA |
Full accounts made up to 31 December 2024
|
|
|
03 Apr 2025 |
PSC02 |
Notification of Rtw Biotech Opportunities Ltd as a person with significant control on 28 March 2025
|
|
|
03 Apr 2025 |
PSC07 |
Cessation of Rtw Biotech Uk Limited as a person with significant control on 28 March 2025
|
|
|
01 Apr 2025 |
RP04CS01 |
Second filing of Confirmation Statement dated 22 September 2024
|
|
|
24 Sep 2024 |
CS01 |
Confirmation statement made on 22 September 2024 with updates
-
ANNOTATION
Clarification a second filed CS01 (statement of capital & shareholder information change) was registered on 01/04/2025.
|
|
|
11 Jul 2024 |
TM02 |
Termination of appointment of Kin Company Secretarial Limited as a secretary on 11 April 2024
|
|
|
11 Jul 2024 |
AP04 |
Appointment of Vistra Cosec Limited as a secretary on 12 April 2024
|
|
|
22 May 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
07 May 2024 |
AD01 |
Registered office address changed from Kin Company Secretarial Limited Hyde Park House 5 Manfred Road London SW15 2RS United Kingdom to Suite 1, 7th Floor 50 Broadway London SW1H 0DB on 7 May 2024
|
|
|
01 Mar 2024 |
SH20 |
Statement by Directors
|
|
|
01 Mar 2024 |
SH19 |
Statement of capital on 1 March 2024
|
|
|
01 Mar 2024 |
CAP-SS |
Solvency Statement dated 29/02/24
|
|
|
01 Mar 2024 |
RESOLUTIONS |
Resolutions
-
RES06 ‐
Resolution of reduction in issued share capital
|
|
|
17 Feb 2024 |
RESOLUTIONS |
Resolutions
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES10 ‐
Resolution of allotment of securities
|
|
|
16 Feb 2024 |
PSC02 |
Notification of Rtw Biotech Uk Limited as a person with significant control on 12 February 2024
|
|
|
16 Feb 2024 |
PSC07 |
Cessation of Arix Bioscience Plc as a person with significant control on 12 February 2024
|
|
|
12 Feb 2024 |
AP01 |
Appointment of Ms Stephanie Sirota as a director on 12 February 2024
|
|
|
12 Feb 2024 |
AP01 |
Appointment of Mr Edward David Stileman as a director on 12 February 2024
|
|
|
12 Feb 2024 |
TM01 |
Termination of appointment of Peregrine David Euan Malcolm Moncreiffe as a director on 12 February 2024
|
|
|
12 Feb 2024 |
TM01 |
Termination of appointment of Thomas Charles Ramsay Davidson as a director on 12 February 2024
|
|
|
12 Feb 2024 |
AD01 |
Registered office address changed from Duke Street House, 50 Duke Street London W1K 6JL England to Kin Company Secretarial Limited Hyde Park House 5 Manfred Road London SW15 2RS on 12 February 2024
|
|
|
12 Feb 2024 |
SH01 |
Statement of capital following an allotment of shares on 9 February 2024
|
|
|
04 Jan 2024 |
TM01 |
Termination of appointment of Robert William Henry Lyne as a director on 31 December 2023
|
|